JGC
GWPH

J. Goldman & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

J. Goldman & Co’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,480
Closed -$743K – 377
2020
Q1 		$743K Buy
+8,480
New +$898K 0.09% 152

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

J. Goldman & Co's GWPH Position: Q2 2020 in Review

J. Goldman & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 8,480 shares — an estimated $743K sold.

J. Goldman & Co first reported a position in GWPH in Q1 2020 and held it in 1 quarter. The position peaked at $743K in Q1 2020. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.

  • J. Goldman & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
  • J. Goldman & Co sold 8,480 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2020, an estimated $743K.
  • J. Goldman & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2020 and held it in 1 quarter.
  • J. Goldman & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $743K in Q1 2020.
  • 299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.

Based on J. Goldman & Co's 13F filing for Q2 2020, filed 14 Aug 2020.